Which ingredients in male enhancement supplements have the strongest randomized‑trial evidence for improving erectile function?

1. Saffron: a small but consistent signal in trials

Saffron has emerged in meta‑analysis as one of the few herbal agents showing statistically significant improvements in erectile function, orgasmic function and intercourse satisfaction versus placebo in randomized trials, giving it among the clearest RCT support of any botanical studied for ED ^{[1] [6]}.

2. Ginseng: plausible benefit but uneven evidence

Multiple randomized trials and a recent systematic review/meta‑analysis report that ginseng—often Korean red ginseng—can improve erectile function, orgasmic function, sexual desire and sometimes serum testosterone, but reviewers emphasize the overall quality is mixed and effect sizes are modest compared with prescription therapies ^{[1] [7]}.

3. L‑arginine and the nitric‑oxide pathway: mechanistic plausibility with variable trial support

L‑arginine, a nitric oxide precursor, has RCT evidence of benefit for some men with ED, particularly vasculogenic cases; parallel trials of nitrate‑rich foods like beetroot have been reported and the NO pathway is a well‑established physiological target for erections, yet trials differ in dose, population and outcomes so certainty is moderate at best ^{[2] [3] [4]}.

4. Flavonoids and polyphenol‑rich foods: endothelial support with modest IIEF gains

Compounds abundant in cocoa, green tea and other polyphenol‑rich foods have been associated in RCTs or pooled analyses with moderate increases in IIEF (International Index of Erectile Function) scores—typically a few points—likely through improved endothelial function and oxidative stress reduction; evidence is promising but not definitive for clinically meaningful restoration in moderate‑to‑severe ED ^[8].

5. Other single agents with limited or inconsistent randomized evidence

Pomegranate juice, some trials of maca, Tribulus terrestris and various herbal extracts have produced mixed or underpowered RCT results; some combinations (for example, yohimbine + L‑arginine) were trialed, but individual agents such as yohimbine/yohimbe raise cardiovascular safety concerns and are excluded from regulatory approval in some regions, limiting practical recommendation ^{[9] [10] [2] [6]}.

6. Multi‑ingredient “male enhancement” products: trials exist but interpretation is fraught

Few proprietary blends have been tested in placebo‑controlled RCTs (for example, VigRX Plus), and while some trials report benefit, industry sponsorship, small samples and the fact that supplements are often adulterated with prescription drugs or unlisted PDE‑5 inhibitors undermine confidence in trial‑derived claims for commercial products ^{[11] [12] [2] [13]}.

7. Safety, quality and regulatory context that shape how trial evidence should be used

Systematic reviewers caution that many marketed supplements are adulterated, mislabelled or lack safety data and that overall the evidence base varies from moderate (saffron, ginseng, L‑arginine) to poor for most botanicals; public health agencies broadly conclude there is no definitive proof that herbal products are universally safe or effective for ED, and clinicians generally prefer regulated prescription PDE‑5 inhibitors for proven efficacy ^{[2] [5] [13] [7]}.

8. Bottom line: what the randomized‑trial record supports and what it doesn’t

RCT data give the strongest, though still qualified, support to saffron, certain ginseng preparations and NO‑targeting agents (L‑arginine/dietary nitrates) for modest improvements in erectile function; flavonoid‑rich foods show promise for endothelial benefit; beyond these, evidence is inconsistent, product quality is a major caveat, and prescription therapies remain the benchmark for efficacy ^{[1] [2] [3] [8] [5]}.